These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 20804085)

  • 21. Re-operation is a safe and effective therapeutic strategy in recurrent WHO grade II gliomas within eloquent areas.
    Martino J; Taillandier L; Moritz-Gasser S; Gatignol P; Duffau H
    Acta Neurochir (Wien); 2009 May; 151(5):427-36; discussion 436. PubMed ID: 19337688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients.
    Ahmadi R; Dictus C; Hartmann C; Zürn O; Edler L; Hartmann M; Combs S; Herold-Mende C; Wirtz CR; Unterberg A
    Acta Neurochir (Wien); 2009 Nov; 151(11):1359-65. PubMed ID: 19575144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combination treatment of malignant brain tumors. Results of initial experiences].
    Bauer B; Adrian G
    Psychiatr Neurol Med Psychol (Leipz); 1983 Sep; 35(9):566-73. PubMed ID: 6316389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risk of increased malignancy a reason for follow-up of low malignancy grade glioma. Early identification of high-risk patients is the key to good care].
    Smits A; Ribom D
    Lakartidningen; 2000 Sep; 97(36):3886-90. PubMed ID: 11036339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing boundaries in the treatment of malignant gliomas.
    Brandes AA; Basso U; Pasetto LM
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):357-70. PubMed ID: 12113103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The European experience with megadose therapy and autologous bone marrow transplantation in solid tumors with poor prognosis Ewing sarcoma, germ cell tumors and brain tumors)].
    Ladenstein R; Gadner H; Hartmann O; Pico J; Biron P; Thierry P
    Wien Med Wochenschr; 1995; 145(2-3):55-7. PubMed ID: 7762255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Controversy on treatments for gliomas].
    Nomura K
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1650-6. PubMed ID: 9757188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-grade gliomas in adults.
    Grier JT; Batchelor T
    Oncologist; 2006 Jun; 11(6):681-93. PubMed ID: 16794247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
    Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
    Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic options for recurrent malignant glioma.
    Niyazi M; Siefert A; Schwarz SB; Ganswindt U; Kreth FW; Tonn JC; Belka C
    Radiother Oncol; 2011 Jan; 98(1):1-14. PubMed ID: 21159396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radio-chemotherapy of inoperable malignant brain gliomas].
    Sciacero P; Cugini A; Geda C; Andreotti M; Ferrari G
    Radiol Med; 1987; 73(1-2):96-8. PubMed ID: 3809641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biology and treatment of malignant glioma.
    Prados MD; Levin V
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):1-10. PubMed ID: 10866344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.
    Sturm D; Pfister SM; Jones DTW
    J Clin Oncol; 2017 Jul; 35(21):2370-2377. PubMed ID: 28640698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Summary version of the Standards, Options and Recommendations for the management of adult patients with intracranial glioma (2002).
    Frappaz D; Chinot O; Bataillard A; Ben Hassel M; Capelle L; Chanalet S; Chatel M; Figarella-Branger D; Guegan Y; Guyotat J; Hoang-Xuan K; Jouanneau E; Keime-Guibert F; Laforêt C; Linassier C; Loiseau H; Maire JP; Menei P; Rousmans S; Sanson M; Sunyach MP; ; ;
    Br J Cancer; 2003 Aug; 89 Suppl 1(Suppl 1):S73-83. PubMed ID: 12915906
    [No Abstract]   [Full Text] [Related]  

  • 35. [Optimization of the radiotherapy for the gliomas: hopes and research axis for the next future].
    Moyal EC
    Rev Neurol (Paris); 2011 Oct; 167(10):656-60. PubMed ID: 21889179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular tools: biology, prognosis, and therapeutic triage.
    Fischer I; Aldape K
    Neuroimaging Clin N Am; 2010 Aug; 20(3):273-82. PubMed ID: 20708546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic evaluations of recurrent gliomas and preliminary efficacies of combined modality therapy].
    Zhang X; Yao Y; Qin ZY; Wang Y; Wu JS; Mao Y; Zhou LF
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(1):11-4. PubMed ID: 23578445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis, treatment, and prognosis of glioma: five new things.
    Taylor LP
    Neurology; 2010 Nov; 75(18 Suppl 1):S28-32. PubMed ID: 21041768
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnosis and prognosis of gliomas--current prospects of molecular diagnostics].
    Haapasalo J; Hyartt A; Salmi M; Nordfors K; Lahtela SL; Kähkönen M; Helén P; Haapasalo H
    Duodecim; 2014; 130(9):893-901. PubMed ID: 24881141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Modern approach to WHO grade II glioma classification and treatment--review of the literature].
    Recławowicz D; Stempniewicz M; Biernat W; Słoniewski P
    Neurol Neurochir Pol; 2008; 42(6):536-45. PubMed ID: 19235107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.